Search results for "FDA update"


 
Results 51 - 60 of about 76 for "FDA update".

FDA update

https://diabetes.acponline.org/archives/2013/05/10/13.htm. The FDA is investigating reports of possible increased risk of pancreatitis and precancerous findings of the pancreas from incretin mimetic drugs ... The FDA is investigating reports of possible
May 2013

FDA update

https://diabetes.acponline.org/archives/2012/10/12/10.htm. A combination of phentermine and topiramate extended-release (Qsymia) was recently approved by the FDA as an addition to a ... A combination of phentermine and topiramate extended-release (Qsymia)
October 2012

FDA update

https://diabetes.acponline.org/archives/2013/06/14/10.htm. The FDA recently approved canaglifozin (Invokana) tablets to improve glycemic control in adults with type 2 diabetes, along with diet and ... exercise. The FDA recently approved canaglifozin
June 2013

FDA update

20. In effect, patients and clinicians can use results directly from the device to make diabetes treatment decisions, according to an FDA press release. ... FDA, which also noted the potential for falsely raised glucose readings with acetaminophen use.
January 2017

FDA update

Dapaglifozin (Farxiga), a new medication to treat type 2 diabetes, was recently approved by the FDA for use along with diet and exercise. ... The FDA also announced a recall of some TRUEbalance and TRUEtrack blood glucose meters by Nipro Diagnostics, Inc.
March 2014

FDA update

Empagliflozin (Jardiance), a sodium glucose co-transporter 2 (SGLT2) inhibitor, was recently approved to treat type 2 diabetes in addition to diet and exercise, the FDA announced last week. ... The FDA is requiring 4 postmarketing studies to investigate
August 2014

FDA update

The FDA has approved marketing of the first medical device to use artificial intelligence to detect diabetes-related eye problems, the agency announced on April 11.
May 2018

FDA update

The FDA has approved marketing of the Dexcom G6 integrated continuous glucose monitoring system to determine blood glucose levels in adults with diabetes and children ages 2 years and older, the ... The system is the first approved to be used with other
April 2018

FDA update

Patients should not use unapproved or unauthorized devices for diabetes management, either alone or with authorized devices, the FDA recently warned. ... In one report, a patient used an unauthorized device that received the electronic signal from an
June 2019

FDA update

The FDA has authorized marketing of the first interoperable insulin pump for patients with diabetes, the agency announced on Feb. ... The FDA reviewed data on dosing accuracy and reliability and assessed the pump's ability to safely communicate with
March 2019

Result Page: Prev   1   2   3   4   5   6   7   8   Next